Table 2

The prevalence of CVRFs, stratified by gender

All (n=6800), %Male (n=2193), %Female (n=4607), %p Value
Obesity, BMI (kg/m2)
 <2546.634.052.6<0.01
 25–2935.945.131.5
 ≥3017.521.015.8
Waist circumference (cm)
 Men ≥100, women ≥9049.449.549.30.89
Smoking17.919.517.20.02
Elevated BP (mm Hg)
 ≥140/9044.052.040.3<0.01
Diabetes—only fasting patients (n=1814, 26.7%) (mg/dL)
 Normal (<101)53.946.457.6<0.01
 IFG (101–116)28.231.326.6
 Diabetes (≥117)18.022.215.9
Diabetes—all patients (mg/dL)
 Normal (<101)86.082.587.7<0.01
 IFG (101–116)7.58.67.0
 Diabetes (≥117)6.58.95.3
Hypercholesterolaemia (mg/dL)
 TC≥20057.247.661.6<0.01
Number of CVRF present*
 Any74.774.674.80.54
 025.325.425.2<0.01
 142.641.343.2
 228.127.928.1
 34.15.33.5
Any new CVRF diagnosis*29.529.729.40.82
Recommendation to consult physician45.043.445.70.07
  • *Including IFG, diabetes, BP, TC, but not smoking or obesity.

  • BMI, body mass index; BP, blood pressure; CVRF, cardiovascular risk factor; IFG, impaired fasting glucose; TC, total cholesterol.